Arcand SL, Provencher D, Mes-Masson A-M, Tonin PN. 2005 OGG1 Cys326 variant, allelic
imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer. Int J Oncol.
5:1315-20.
Arnes
JB, Brunet JS, Stefansson I, Begin LR, Wong N, Chappuis
PO, Akslen LA, Foulkes
WD. Placental cadherin and the basal
epithelial phenotype of BRCA1-related breast cancer. Clin
Cancer Res. 11(11): 4003-11, 2005.
Belanger H., Beaulieu P.,
Moreau C., Labuda D., Hudson T.J., Sinnett D. Functional promoter SNPs
in cell cycle checkpoint genes. Hum Molec Genet. 14:2641-8,
2005.
Boycott, K.M., S. Flavelle, A. Bureau, H.C. Glass, T.M. Fujiwara, E. Wirrell, K. Davey, A.E. Chudley, J.N. Scott, D.R. McLeod, and J.S. Parboosingh: Homozygous deletion of the very low density
lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with
cerebral gyral simplification. Am
J Hum Genet. 77:477-483, 2005.
Callén E, Casado JA, Tischkowitz MD, Bueren
JA, Creus A, Marcos R, Dasí
A, Estella JM, Muñoz A, Ortega JJ, de Winter J, Joenje H, Schindler D, Hanenberg
H, Hodgson SV, Mathew CG, Surrallés J. A common
founder mutation in FANCA underlies the world highest prevalence of Fanconi anemia in Gypsy families
from
Caron, J., Loredo-Osti J.C., Morgan K., Malo D. Mapping of interactions and mouse congenic strains identified novel epistatic
QTLs controlling the persistence of Salmonella
enteritidis in mice. Genes Immun. 6:500-508, 2005.
Chappuis PO, Donato E, Goffin JR, Wong N, Begin LR, Kapusta
LR, Brunet JS, Porter P, Foulkes
WD. Cyclin E
expression in breast cancer: predicting germline
BRCA1 mutations, prognosis and response to treatment. Ann Oncol. 16 (5): 735-742, 2005.
Coelho JJ,
Arnold A, Naylor J, Tischkowitz M,
MacKay J. An assessment of
the efficacy of cancer genetic counseling using real-time videoconferencing
technology (Telemedicine) compared to face-to-face consultations. Eur J Cancer. 2005 41 (15): 2257-2261.
Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, Thoresen SO, Foulkes WD,
Akslen LA. A Basal epithelial phenotype is more
frequent in interval breast cancers compared with screen detected tumors. Cancer
Epidemiol Biomarkers Prev.
14 (5): 1108-12, 2005.
Croteau S., Roquis D., Charron M.C., Frappier D., Yavin D., Loredo-Osti
J.C., Hudson T.J., Naumova A.K. (2005).
Increased plasticity of genomic imprinting of Dlk1 in brain is due to genetic
and epigenetic factors. Mamm Gen. Feb; 16(2):
127-35, 2005.
Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch
HT, Isaacs C, Weber B, Moller P, Offit
K, Kim-Sing C, Friedman E, Randall S, Pasini B,
Ainsworth P, Gershoni-Baruch R, Foulkes
WD, Klijn J, Tung N, Rennert
G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2
mutation carriers. Int J Cancer. 117
(6): 988-91, 2005.
Denarier E., Forghani R., Farhadi H., Dib S., Dionne N., Friedman H., Lepage P., Hudson T.J., Drouin
R., Peterson A.C. Functional organization of a Schwann cell enhancer. J Neurosc. Nov 30; 25(48):
11210-7, 2005.
Desrosiers, M.-P., Kielczewska A., Loredo-Osti J.C., Girard Adam S., Makrigiannis A.P., Lemieux S.,
Pham T., Lodoen M.B., Morgan K., Lanier L.L.,
Vidal S.M. Epistasis between mouse Klra and major histocompatibility
complex class I loci is associated with a new mechanism of natural killer
cell-mediated innate resistance to cytomegalovirus infection. Nat Genet.
37:593-599, 2005.
Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch
R, Friedman E, Rennert G, Wagner T, Isaacs C,
Kim-Sing C, Ainsworth P, Sun P, Narod SA. Breast
cancer risk following bilateral oophorectomy in BRCA1
and BRCA2 mutation carriers: an international case-control study. J Clin Oncol.
23 (30): 7491-6, 2005.
Ernest S, Hosack
A, O’Brien WE, Rosenblatt DS, and Nadeau
JH: Homocysteine levels in A/J and C57BL/6J mice:
genetic, diet, gender, and parental effects. Physiol
Genom. 21(3): 404-410, 2005.
Ferrier DE, Dewar K, Cook A, Chang JL, Hill-Force A, Amemiya C. The chordate ParaHox cluster. Curr
Biol. 2005 Oct 25; 15(20): R820-2.
Florez J.C., C.M. Agapakis, P. Burtt, M. Sun, P. Almgren, L. Rästam, T. Tuomi, D.Gaudet, T. J. Hudson, M. J. Daly, K. G. Ardlie, J. N. Hirschhorn, L. Groop and D. Altshuler (2005). Association testing of the protein tyrosine phosphatase
1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes.
54(6): 1884-91.
Foulkes WD, Hamel
N, Oros KK, Tonin
PN. 2005. Double heterozygosity and founder
mutations in BRCA1/2 in women with ductal carcinoma
in situ. JAMA. 294:553-4 [Letter to the editor].
Frosk, P.F., Greenberg C.R., Tennese
A.A.P., Lamont R., Nylen E., Hirst
C., Frappier D., Roslin
N.M., Zaik M., Bushby K.,
Straub V., Zatz M., de Paula F., Morgan K., Fujiwara
T.M., and Wrogemann K.W.: The most common
mutation in FKRP causing limb girdle muscular dystrophy type 2I (LGMD2I)
may have occurred only once and is present in Hutterite
and other populations. Hum Mutat. 25:38-44,
2005.
Ge B., Gurd S., Gaudin T., Dore C., Lepage P., Harmsen E., Hudson T.J., Pastinen
T. Survey of allelic expression using EST mining. Genome Res. Nov
15:1584-91, 2005.
Gilfix BM.
Vitamin B12 and Homocysteine. CMAJ. 2005;
173(11): 1360.
Glass, H.C., Boycott K.M,
Adams C., Barlow K., Scott J.N., Chudley A.E., Fujiwara
T.M., Morgan K., Wirrell E., McLeod D.R.: Autosomal recessive cerebellar hypoplasia in the Hutterite
population. Develop Med Child Neurol.
47:691-695, 2005.
Guigonis V, Frémeaux-Bacchi V, Giraudier S, Favier R, Borderie D, Massy Z, Mougenot, Rosenblatt DS, and Deschênes
G: Late-onset thrombocytic microangiopathy
caused by cblC disease: Associated with a
factor H mutation. Am J Kidney Dis.
45(3): 588-595, 2005.
Hamet P., Merlo E., Seda O., Broeckel U., Tremblay J., Kaldunski
M., Gaudet D., Bouchard G, Deslauriers
B., Gagnon F., Antoniol G., Pausova
Z., Labuda M, Jomphe M, Gossard F., Tremblay G., Kirova
R., Tonellato P., Orlov
S.N., Pintos J., Platko J., Hudson T.J., Rioux J.D., Kotchen T.A., Cowley
A.W. Quantitative founder-effect analysis of French Canadian families identifies
specific Loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet. 2005 May; 76(5): 815-32. Epub 2005 Mar 30.
Honrado E, Osorio A, Palacios J, Milne RL, Sanchez L, Diez O, Cazorla A, Syrjakoski K, Huntsman D, Heikkila
P, Lerma E, Kallioniemi A,
Rivas C, Foulkes WD, Nevanlinna H, Benitez J. Immunohistochemical
expression of
cancer differentiate BRCA2-associated tumors. J Clin Oncol.
23 (30): 7503-11, 2005.
International
HapMap Consortium, (Hudson TJ, co-author). A haplotype
map of the human genome. Nature. Oct
437:1299-320, 2005.
Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs
C, Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P, Friedman E, Daly M, Garber
JE, Karlan B, Olopade OI,
Tung N, Saal HM, Eisen A,
Osborne M, Olsson H, Gilchrist D, Sun P, Narod
SA. Age at menarche and the risk of breast cancer in
BRCA1 and BRCA2 mutation carriers. Cancer Causes Cont. 16 (6):
667-674, 2005.
Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J,
Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth
P, Foulkes WD, Eisen
A, Sun P, Narod SA. Changes in body weight and the risk of breast cancer in BRCA1 and
BRCA2 mutation carriers. Breast Cancer Res. 7 (5): R833-R843,
2005.
Laflamme,
N, Giroux S, Loredo-Osti JC, Elfassihi L, Dodin S, Blanchet C, Morgan K, Giguère
V, Rousseau F: A frequent regulatory variant of the
estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women. J Bone Mineral.
Res 20:938-944, 2005.
Lamont,
R, Loredo-Osti JC, Roslin
NM, Mauthe J, Coghlan G, Nylen E, Frappier D, Innes AM, Lemire EG, Lowry RB,
Greenberg CR, Triggs‑Raine BL, Morgan K,
Wrogemann K, Fujiwara TM, Zelinski
T. A locus for Bowen-Conradi syndrome maps to
chromosome region 12p13.3. Am J Med Genet.
132A: 136-143, 2005.
Lincoln M.R., Montpetit A, Cader
MC, Saarela J, Dyment DA, Tiislar M, Ferretti V, Tienari PJ, Sadovnick AD, Peltonen L, Ebers CG, Hudson
TJ. A predominant role for the HLA class II region in the
association of the
Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault
AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S,
Dewar K, Hudson TJ, Horn R, Rene P, Monczak
Y, Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea
with high morbidity and mortality. N Engl J
Med. 2005 Dec 8; 353(23): 2442-9. Epub 2005 Dec
1.
Loredo-Osti, JC,
Makrigiannis AP, Patel D, Goulet M-L, Dewar
K, Anderson SK. Direct Sequence Comparison of Two Divergent Class I
Makriyianni I, Hamel N, Ward S, Foulkes
WD, Graw S. BRCA1:185delAG found in the
McVety S, Younan R, Li
L, Gordon PH, Wong N, Foulkes WD, Chong G. Novel genomic insertion-- deletion in MLH1:
possible mechanistic role for non-homologous end-joining
Morel CF, Scott P, Christensen
E, Rosenblatt DS, Rozen R: Prenatal
diagnosis for severe methylenetetrahydrofolate reductase deficiency by linkage analysis and enzymatic
assay. Mol Genet Metab.
85(2): 115-120, 2005.
Morel CF, Watkins D,
Scott P, Rinaldo P, Rosenblatt DS:
Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12
metabolism and transport. Mol Genet Metab.
86:160-171, 2005.
Morgan NV, Essop F, Demuth I, de Ravel T, Jansen S, Tischkowitz M, Lewis CM, Wainwright L, Poole
J, Joenje H, Digweed M,
Krause A, Mathew CG. A common Fanconi
anaemia mutation in Black populations of Sub-Saharan
Africa. Blood. 1; 105(9): 3542-4, 2005.
New HV, Cale CM, Tischkowitz
M, Flores De Laurnaga B, Jones A, Telfer P, Veys P, D’Andrea A, Mathew CG, Hann I. Nijmegen breakage
syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer. 44(5): 494-9,
2005.
Nusbaum C, Zody
MC, Borowsky ML, Kamal M, Kodira CD, Taylor TD, Whittaker CA, Chang JL, Cuomo CA, Dewar
K, FitzGerald MG, Yang X, Abouelleil A, Allen NR,
Anderson S, Bloom T, Bugalter B, Butler J, Cook A, DeCaprio D, Engels R, Garber M, Gnirke
A, Hafez N, Hall JL, Norman CH, Itoh T, Jaffe DB,
Kuroki Y, Lehoczky J, Lui
A, Macdonald P, Mauceli E, Mikkelsen
TS, Naylor JW, Nicol R, Nguyen C, Noguchi H, O'Leary
SB, O'Neill K, Piqani B, Smith CL, Talamas JA, Topham K, Totoki Y, Toyoda A, Wain HM,
Young SK, Zeng Q, Zimmer AR, Fujiyama A, Hattori M, Birren BW, Sakaki Y, Lander ES.
Ouellet V, Provencher DM, Maugard CM, Le Page C, Ren F, Ren F, Lussier C, Novak J, Ge B, Hudson
TJ, Tonin PN, Mes-Masson A-M.
2005. Discrimination
between serous low malignant potential and invasive epithelial ovarian tumors
using molecular profiling. Oncogene.
24: 4672-87.
Pastinen T, Ge B, Gurd S, Gaudin
T, Dore C, Lemire M, Lepage
P, Harmsen E and Hudson TJ. Mapping
common regulatory variants to human haplotypes.
Hum Molec Genet. 2005 Dec 15; 14(24): 3963-71.
Epub 2005 Nov 21.
Pausova Z, Gaudet D, Gossard F, Bernard M, Kaldunski
ML, Jomphe M, Tremblay J, Hudson TJ, Bouchard
G, Kotchen TA, Cowley AW, Hamet
P. Genome-wide scan for linkage to obesity-associated hypertension in French
Canadians. Hypertension. Dec;
46: 1280 – 1285, 2005.
Poon AH, Laprise C, Lemire M, Hudson TJ, Schurr E. NRAMP1 is not associated with asthma, atopy, and serum immunoglobulin E levels in the French
Canadian population. Genes Immun. 6(6):
519-27, 2005.
Presneau N, Dewar K,
Forgetta V, Provencher D, Mes-Masson A-M, Tonin
PN. 2005. Loss of heterozygosity and transcriptome
analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at
17q25.1-q25.2 Mol Carcinog. 43: 141-54.
Presneau N, Shen Z, Provencher D, Mes-Masson
A-M, Tonin PN. 2005. Identification of novel variant, 1484delG in the 3'
Qu H, Bharaj B, Liu XQ, Curtis JA, Newhook
LA, Paterson AD, Hudson TJ, Polychronakos C.
Assessing the validity of the association between the SUMO4 M55V variant and
risk of type 1 diabetes. Nat Genet. 2005 Feb; 37(2): 111-2, 2005.
Qu H, Tessier MC, Hudson
TJ, Polychronakos C. Confirmation of the association of the R620W
polymorphism in the protein tyrosine phosphatase PTPN22
with type 1 diabetes in a family based study. J Med Genet.
2005 Mar; 42(3): 266-270, 2005.
Rosel PE, Forgetta V, Dewar
K. (2005). Isolation and characterization of twelve
polymorphic microsatellite markers in bottlenose dolphins
(Tursiops truncatus).
Molec. Ecology Notes (in press).
Serre D, Nadon R & Hudson TJ. Large-scale recombination rate patterns are conserved
among human populations. Genome Res. Nov 15;
1547-1552, 2005.
Su Z, Segura M, Morgan K,
Loredo-Osti JC, Stevenson MM. Impairment
of protective immunity to blood-stage malaria by concurrent nematode infection.
Infec Immun.73:3531-3539, 2005.
Sun S,
Tessier M-C, Qu H, Fréchette R, Bacot F, Grabs R, Taback SP, Lawson M,
Kirsch S, Hudson TJ, Polychronakos C. Type 1 diabetes and the OAS gene cluster: association
with splicing polymorphism or haplotype? J Med Genet. 2005 July 13; [Epub ahead of print].
Tonin PN, Forgetta V, Provencher D, Presneau N, Mes-Masson A-M, Dewar K. (2005) Loss of heterozygosity
and transcriptome analysesof
a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at
17q25.1-q25.2. Molec Carcinogen. (In
press).
van der
Klift H, Wijnen J, Wagner
A, Verkuilen P, Tops C, Otway R, Kohonen-Corish
M, Vasen H, Oliani C, Barana D, Moller P, Delozier-Blanchet C, Hutter P, Foulkes WD, Lynch H, Burn J, Moslein G, Fodde R.
Molecular characterization of the spectrum of genomic deletions in the mismatch
repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromos
Cancer. 44 (2): 123-38, 2005.
Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D,
Lynch HT, McLennan J, Foulkes WD,
Wagner T, Tung N, Ghadirian P, Olopade
O, Isaacs C, Kim-Sing C, Moller P, Neuhausen SL, Metcalfe K, Sun P, Narod
SA. A comparison of bilateral breast cancers in BRCA
carriers. Cancer Epidemiol
Biomarkers Prev. 14 (6): 1534-8, 2005.
Winckler W, Graham RR, de Bakker
PI, Sun M, Almgren P, Tuomi
T, Gaudet D, Hudson TJ, Ardlie
KG, Daly MJ, Hirschhorn JN, Groop
L, Altshuler D. Association testing of variants in
the hepatocyte nuclear factor 4{alpha} gene with risk
of type 2 diabetes in 7,883 people. Diabet. Mar 54(3): 886-92, 2005.
Winckler W, Burtt NP, Holmkvist J, Cervin C, de Bakker PI, Sun M, Almgre P, Tuomi T, Gaudet D, Hudson TJ,
Ardlie KG, Daly MJ, Hirschhorn
JN, Altshuler D, Groop
L. Association of common variation in the HNF1 alpha gene region with risk of
type 2 diabetes. Diabet. 54:
2336-42, 2005.
Xu J, Dimitrov L, Chang BL,
Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard
J, Giles GG, Hopper JL, Mahle L, Moller
P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S,
Hope Q, Hsieh CL, Halpern J, Balise
RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S,Schaid DJ, Friedrichsen DM,
Deutsch K, Kolb S, Badzioch M, Jarvik
GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange
EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer
K, Hoegel JJ, Vogel W, Paiss
T, Wiklund F, Emanuelsson
M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J,
Cannon-Albright LA, Seminara D; ACTANE Consortium.
A combined genomewide linkage scan
of 1,233 families for prostate cancer-susceptibility genes conducted by the
international consortium for prostate cancer genetics. Am
J Hum Genet. 77 (2): 219-29, 2005.
Yotova V, Labuda D, Zietkiewicz E, Gehl D, Lovell A,
Lefebvre JF, Bourgeois S, Lemieux-Blanchard E, Labuda M, Vezina H, Houde L, Tremblay M, Toupance B, Heyer E, Hudson TJ, Laberge
C. Anatomy of a founder effect: myotonic dystrophy in
Northeastern Quebec. Hum Genet.117: 177-87, 2005.
Zauber NP, Sabbath-Solitare M, Marotta S, Zauber AG, Foulkes WD, Chan M, Turner F, Bishop
DT. Clinical and genetic findings in an Ashkenazi
Jewish population with colorectal neoplasms. Cancer. 15: 104 (4): 719-29, 2005.
Members
| Report | Meetings
Publications
| Funds | Financial
© 2006 Finestone Laboratory